Abstract
The antibiotic 9-beta-D-arabinofuranosyladenine is a drug with a broad spectrum of activity against animal viruses, with little or no effect on mammalian cells, when administered in vivo or in vitro. Here we report that the antibiotic markedly inhibited the incorporation of [35S]methionine into malarial protein. Inhibition was apparent when the parasites were either exposed to the drug in vivo during the course of infection or incubated with the drug in vitro. Moreover, the antibiotic induced pronounced changes in the spectrum of proteins synthesized. Some proteins that are prominently apparent in the control disappear from the drug-treated parasites; others specific for drug-treated parasites appear, indicating changes in the commitment for gene expression as manifested by the appearance of the final protein product. Proteins synthesized were analyzed by two-dimensional polyacrylamide gels; the first dimension used isoelectric focusing in cylinder gels and the second dimension used electrophoresis in a lithium dodecyl sulfate slab gel. Proteins were visualized by radioautography.
MeSH Terms
Animals
Blood Cells/drug effects,metabolism
Blood Proteins/biosynthesis
Erythrocytes
Genes
Isoelectric Focusing
Kinetics
Plasmodium berghei/drug effects,genetics,metabolism
Protein Biosynthesis/drug effects
Vidarabine/pharmacology
Chemicals
Blood Proteins
Vidarabine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ilan J
Pierce D R
Miller F W
References (18)
18 references, click to expand
-
Toxicity of 9-beta-D-arabinofuranosyladenine in mice and rabbits.
Antimicrob Agents Chemother (Bethesda). 1968;8:180-9
PMID: 5735360
-
Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.
Antimicrob Agents Chemother (Bethesda). 1968;8:148-54
PMID: 5735359
-
Antiviral activity of 9-beta-D-arabinofuranosyladenine. I. Cell culture studies.
Antimicrob Agents Chemother (Bethesda). 1968;8:136-47
PMID: 5735358
-
5'-Nucleotides as potential formulations for administering nucleoside analogs in man.
Cancer Res. 1972 Nov;32(11):2441-4
PMID: 4678086
-
Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 9-beta-D-arabinofuranosyladenine.
Cancer Res. 1967 Sep;27(9):1528-33
PMID: 4860891
-
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man.
J Infect Dis. 1973 Nov;128(5):658-63
PMID: 4358651
-
The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A).
Chemotherapy. 1968;13(6):321-38
PMID: 4305653
-
High resolution two-dimensional electrophoresis of proteins.
J Biol Chem. 1975 May 25;250(10):4007-21
PMID: 236308
-
Nucleosides and nucleotides: past, present, and future.
Ann N Y Acad Sci. 1975 Aug 8;255:597-610
PMID: 171998
-
Susceptibility to Plasmodium berghei: parasitological biochemical and hematological studies in laboratory and wild mammals.
Mil Med. 1966 Sep;131(9):Suppl:859-69
PMID: 4957835
-
Aminoacyl transfer ribonucleic acid synthetases from cell-free extract of Plasmodium berghei.
Science. 1969 May 2;164(3879):560-2
PMID: 4888104
-
Complete solubilization of ribosomal proteins during the fractionation of mouse liver ribosomal proteins by two-dimensional polyacrylamide gel electrophoresis.
Prep Biochem. 1976;6(1):13-26
PMID: 1273035
-
Analysis by two-dimensional polyacrylamide gel electrophoresis of the in vivo phosphorylation of ribosomal proteins derived from free and membrane-bound polysomes.
Mol Biol Rep. 1975 Oct;2(3):219-24
PMID: 1196310
-
Phosphorylation of D-Arabinosyl adenine by Plasmodium berghei and its partial protection of mice against malaria.
Nature. 1970 Dec 26;228(5278):1300-1
PMID: 5488096
-
Inhibition of rodent malaria in mice by rifampicin.
Nature. 1970 Jul 25;227(5256):381-2
PMID: 5428437
-
Exogenous interferon protects mice against Plasmodium berghei malaria.
Nature. 1970 Sep 26;227(5265):1350-1
PMID: 5455140
-
Role of interferon in experimental mouse malaria.
Nature. 1968 Nov 16;220(5168):709-10
PMID: 5688146
-
Interferon inducers protect mice against plasmodium berghei malaria.
Science. 1968 Aug 23;161(3843):802-4
PMID: 5663811